Autoimmune Drugs

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Eli Lilly has entered a multi-billion dollar agreement to acquire Merida to bolster its pipeline of autoimmune treatments targeting rogue antibodies.

6 sources 6 articles v 4 1h ago